Geek News: Latest Technology, Product Reviews, Gadgets and Tech Podcast News for Geeks

TabSafe Medication Management System for Independent Living

Posted by Andrew at 3:21 PM on February 8, 2011

Andy and Esbjorn interview Chris Morgan and James Chiavetta from TabSafe, who demonstrate their Medication Management System, which won a Design and Engineering Showcase Award at CES.

TabSafe is an in-home medication dispensing system aimed at keeping seniors and chronically ill at home, rather than taking them into care or assisted-living accommodation. Apparently 1 in 4 people have to move out of their homes because of problems taking medication.

The system comprises there parts – a base unit, a medication cartridge and a personal health website. Where needed, multiple medication cartridges can be used for different prescriptions. The system is programmed with the time and frequency of medication dispensing and when the time comes, the patient is alerted via a tone and a customisable voice prompt to take their tablets.

If the patient doesn’t take their medication on time, the carer is alerted by the system via their mobile phone.

The personal health website is used by the carer or patient to program TabSafe but information is returned from the TabSafe to the website so a time-based view of the medication dispensing can be seen and passed to their physician. TabSafe connects to the Internet via router but it has a backup connection through the standard telephone system.

Chris and James also discuss some of the challenges developing a home medical device to the market, including legal issues and failsafes.

On sale now for $1099 plus $10 per month for the personal health website.

Interview by Andy McCaskey of SDR News and Esbjorn Larsen of MrNetCast.com.

Please Support our CES 2011 Sponsors.

Get your 14 day Free Trial of Audible Gold to start listening to great books!
Save 25% on 4GH Hosting 1yr Subscriptions Save 25% Promo Code CES2.
Sponsor: The New Luxor, Las Vegas Deals Start @ $40.00 best rates guaranteed.

Comments are closed.